These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 24951855

  • 1. The use of stimulant medications for non-core aspects of ADHD and in other disorders.
    Sinita E, Coghill D.
    Neuropharmacology; 2014 Dec; 87():161-72. PubMed ID: 24951855
    [Abstract] [Full Text] [Related]

  • 2. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder.
    Gibson AP, Bettinger TL, Patel NC, Crismon ML.
    Ann Pharmacother; 2006 Jun; 40(6):1134-42. PubMed ID: 16735655
    [Abstract] [Full Text] [Related]

  • 3. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 4. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB, Walker DJ.
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [Abstract] [Full Text] [Related]

  • 5. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J.
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Psychostimulants: An Overview].
    Fukumoto S, Imanari E, Tomari S, Higashi T, Kosaka H.
    Brain Nerve; 2023 May; 75(5):599-604. PubMed ID: 37194538
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
    Mohammadi M, Akhondzadeh S.
    Acta Med Iran; 2011 May; 49(8):487-98. PubMed ID: 22009816
    [Abstract] [Full Text] [Related]

  • 15. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC, Khoza S, Oladapo A.
    Curr Med Res Opin; 2011 May; 27 Suppl 2():13-22. PubMed ID: 21973228
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 2011 May; 16(2):1-37. PubMed ID: 10868163
    [Abstract] [Full Text] [Related]

  • 17. Reduction of bulimia nervosa symptoms after psychostimulant initiation in patients with comorbid ADHD: five case reports.
    Keshen A, Ivanova I.
    Eat Disord; 2013 May; 21(4):360-9. PubMed ID: 23767675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
    Shmueli D, Gross-Tsur V.
    Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
    [Abstract] [Full Text] [Related]

  • 20. Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorder.
    Heal DJ, Gosden J, Smith SL.
    Adv Pharmacol; 2024 Aug; 99():251-286. PubMed ID: 38467483
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.